TYPHARM DEVELOPMENTS LIMITED

Active Norwich

Manufacture of basic pharmaceutical products

2 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
T

TYPHARM DEVELOPMENTS LIMITED

Manufacture of basic pharmaceutical products

Founded 29 Oct 2012 Active Norwich, United Kingdom 2 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products

Previous Company Names

GAG365 LIMITED 29 Oct 2012 — 3 May 2013
Accounts Submitted 18 Dec 2025 Next due 31 Dec 2026 7 months remaining
Confirmation Submitted 11 Mar 2026 Next due 24 Mar 2027 9 months remaining
Net assets £16M £4M 2024 year on year
Total assets £16M £4M 2024 year on year
Total Liabilities £226K £42K 2024 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

Unit 39 Mahoney Green Green Lane West Rackheath Norwich Norfolk NR13 6JY

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for TYPHARM DEVELOPMENTS LIMITED (08272004), an active life sciences and medical technology company based in Norwich, United Kingdom. Incorporated 29 Oct 2012. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type total-exemption-full
Next accounts 31 Mar 2026
Due by 31 Dec 2026 7 months remaining

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£5.84k

Decreased by £5.02M (-100%)

Net Assets

£15.91M

Increased by £4.39M (+38%)

Total Liabilities

£226.18k

Increased by £41.66k (+23%)

Turnover

N/A

Employees

2

Debt Ratio

1%

Decreased by 1 (-50%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Ondhia, Parveen ChandrakantDirectorBritishEngland7130 Jul 2014Active

Shareholders

Shareholders (6)

Chandra Ondhia
26.7%
2,671
Mr Chandrakant Vallabhas Ondhia And Mrs Parveen Chandrakant Ondhia As Trustees Of The Mr & Mrs Ondhia Discretionary Settlement 2020
25.0%
2,500

Persons with Significant Control

Persons with Significant Control (4)

4 Active

Parveen Chandrakant Ondhia

British

Active
Notified 21 Mar 2023
Residence England
DOB September 1954
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Chandrakant Vallabhdas Ondhia

British

Active
Notified 6 Apr 2016
Residence England
DOB April 1954
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Mr Chandrakant Vallabhdas Ondhia

British

Active
Notified 6 Apr 2016
Residence United Kingdom
DOB April 1954
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Mrs Parveen Chandrakant Ondhia

British

Active
Notified 21 Mar 2023
Residence England
DOB September 1954
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Group Structure

Group Structure

TYPHARM DEVELOPMENTS LIMITED Current Company
TYPHARM LIMITED united kingdom

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
11 Mar 2026Confirmation StatementConfirmation statement made on 10 Mar 2026 with updates
18 Dec 2025AccountsAnnual accounts made up to 31 Mar 2025
25 Nov 2025Persons With Significant ControlChange to Mr Chandrakant Vallabhdas Ondhia as a person with significant control on 25 Nov 2025
13 Mar 2025Confirmation StatementConfirmation statement made on 10 Mar 2025 with no updates
8 Jan 2025MortgageMortgage Satisfy Charge Full
11 Mar 2026 Confirmation Statement

Confirmation statement made on 10 Mar 2026 with updates

18 Dec 2025 Accounts

Annual accounts made up to 31 Mar 2025

25 Nov 2025 Persons With Significant Control

Change to Mr Chandrakant Vallabhdas Ondhia as a person with significant control on 25 Nov 2025

13 Mar 2025 Confirmation Statement

Confirmation statement made on 10 Mar 2025 with no updates

8 Jan 2025 Mortgage

Mortgage Satisfy Charge Full

Recent Activity

Latest Activity

Confirmation statement made on 10 Mar 2026 with updates

2 months ago on 11 Mar 2026

Annual accounts made up to 31 Mar 2025

5 months ago on 18 Dec 2025

Change to Mr Chandrakant Vallabhdas Ondhia as a person with significant control on 25 Nov 2025

6 months ago on 25 Nov 2025

Confirmation statement made on 10 Mar 2025 with no updates

1 years ago on 13 Mar 2025

Mortgage Satisfy Charge Full

1 years ago on 8 Jan 2025